Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12621780 | 0.99 | ALDH1A1 (0.32) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL30472768 | 0.99 | ALDH1A1 (0.32) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL12621787 | 0.92 | CYP1A2 (0.33) | MAPT | |
| SCHEMBL12621810 | 0.92 | BACE1 (0.32) | ALDH1A1MAPTHTT | |
| SCHEMBL12621772 | 0.90 | GRIN1 (0.32) | ALDH1A1HTTLMNA | |
| SCHEMBL12621795 | 0.89 | ALDH1A1 (0.38) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL12622255 | 0.88 | ALDH1A1 (0.38) | ALDH1A1MAPTHTTLMNA | |
| SCHEMBL12621894 | 0.86 | ALDH1A1 (0.32) | ALDH1A1MAPTHTT | |
| SCHEMBL12622012 | 0.86 | GPR119 (0.35) | — | |
| SCHEMBL12376076 | 0.84 | MAOA (0.33) | TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951305-B2 | Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090267026-A1 | COMPOUND HAVING HYDROCOUMARIN SKELETON, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090267026-A1 | COMPOUND HAVING HYDROCOUMARIN SKELETON, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | HCN2, PIEZO1, TRPV4 | ALDH1A1 3098/4885MAPT 251/4885HTT 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.